Skip to main content
. 2021 Dec 31;4(1):vdab192. doi: 10.1093/noajnl/vdab192

Table 2.

Effective Compounds (S2) With CNS-MPO > 4 Ranked by Most Negative sRGES for GBM

Drug Rank GBM MES CLA PRO
1 Nadifloxacin Levalbuterol Panobinostat Nadifloxacin
2 Panobinostat Enalaprilat Trichostatin-a Enalaprilat
3 Enalaprilat Panobinostat Nadifloxacin Panobinostat
4 Ranolazine Nadifloxacin Dacinostat Levisoprenaline
5 Trichostatin-a Ranolazine Ranolazine Ranolazine